Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling	Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, bone marrow disorder, childhood ependymoma, hematologic disorder, histiocytosis, immune system disorder, immunoproliferative disorder, interdigitating dendritic cell sarcoma, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, malignant histiocytosis, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-08-26		NCT05857969

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Ascent Biomedical Inc.	2
Florida International University	31
National Institute on Minority Health and Health Disparities (NIMHD)	217
Nicklaus Children's Hospital f/k/a Miami Children's Hospital	7

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Nicklaus Children's Hospital	Miami	United States	112